MIRA INFORM REPORT

 

 

Report Date :

21.04.2014

 

IDENTIFICATION DETAILS

 

Name :

MEYER ORGANICS PRIVATE LIMITED

 

 

Registered Office :

A-177, Road No. 16 (Z), Wagle Industrial Estate, Thane - 400604, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

07.02.1981

 

 

Com. Reg. No.:

11-023845

 

 

Capital Investment / Paid-up Capital :

Rs.4.939 Millions

 

 

CIN No.:

[Company Identification No.]

U24239MH1981PTC023845

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PNEM07443C

 

 

PAN No.:

[Permanent Account No.]

AABCM9346B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacture of Pharmaceutical Formulation

 

 

No. of Employees :

Not Available (We tried to confirm the number of employees but no one is ready to part any information from the company management).

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (58)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 4600000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having good track record.

 

Latest financials of 2013 is not available with government department.

 

As per financials of 2012, fundamentals of the company is decent. Financials position of the company is strong and healthy.

 

Trade relations are reported to be fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

The company can be considered for normal for business dealing at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

US investment bank Goldman Sachs has upgraded its outlook on Indian markets as it expects positive impact of the election cycle.

 

India’s economy may grow 4.7 % in the current financial year, lower than the official estimate of 4.9 %, Fitch Rating said. The global rating agency expects the economy to pick up in the next two financial years.

 

Global ratings agency Standard & Poor said increasing focus by India Inc on lowering debt is likely to improve their credit profiles.

 

Singapore (1.1 million Indian tourists in 2012), Thailand (one million), the United Arab Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred holidays hotspots for Indians. The total figure is expected to increase to 1.93 million by 2017, according to the latest Eurmonitor international report.

 

There is a $29.34 bn outward foreign direct investment by domestic companies between April and January of 2013/14 which has seen some signs of recovery according to a Care Ratings report.

 

There are 264 number of new companies being set up every day on average during 2014. Most of them are registered in Mumbai. India had 1.38 million registered companies at the end of January, 2014.

 

Twitter like messaging service Weibo Corporation has filed to raise $ 500 million via a US initial public offering. Alibaba, which owns a stake in Weibo is expected to raise about $ 15 billion New York this year in the highest profile Internet IPO since Facebook’s in 2012.

 

Bharti Airtel has raised Rs.2,453.2 crore (350 million Swiss Francs) by selling six-year bonds at a coupon rate of three per cent and maturing in 2020. This is the largest ever bond offering by an Indian company in Swiss Francs. Bharat Petroleum Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98 % coupon rate in February.

 

Indian Oil Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex at its almost complete Paradip refinery in Odhisha in three to four years. The company board is set to consider the setting up of a 700000 tonne per annum polypropylene plant at an estimated cost at Rs.3150 crore.

 

Global chief information officers at gathering in Bangalore in April to meet Indian startups at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in the making.


 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DENIED BY

 

Name :

Ms. Saruchi Athavle

Designation :

Accounts Department

Contact No.:

91-22-25817000 / 7035

Date :

18.04.2014

 

 

LOCATIONS

 

Registered Office :

A-177, Road No. 16 (Z), Wagle Industrial Estate, Thane - 400604, Maharashtra, India

Tel. No.:

91-22-25817000 / 7035

Fax No.:

91-22-25817002 / 25817030

E-Mail :

cbendre@meyer.co.in

infor@meyer.co.in

techicalQA@meyer.co.in

buysel@meyer.co.in

careers@meyer.co.in

webmaster@meyer.co.in

sathavale@meyer.co.in

ukalekar@meyer.co.in

Website :

http://www.meyer.co.in

Location :

Owned

 

 

Head Office /Administrative Office :

A-303, Road No. 31/32, Wagle Industrial Estate, Thane West, Thane - 400601, Maharashtra, India

Tel. No.:

91-22-25817000

Fax No.:

91-22-25817002

E-Mail :

info@meyer.co.in

 


 

DIRECTORS

 

As on 30.09.2013

 

Name :

Mrs. Pushpa Kalsey

Designation :

Director

Address :

No. 42, fortune vally, 13/2, hariyanpalya, dasara halli, village hebbi, Bangalore – 560024, Karnataka, India

Date of Birth/Age :

11.07.1942

Date of Appointment :

30.09.2013

DIN No.:

01711674

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U29253KA1983PTC005450

BRITISH TOOL HOUSE PRIVATE LIMITED

Director

18/07/1983

18/07/1983

-

Active

NO

2

U70101KA1995PTC018530

MONT BLANC ESTATES PRIVATE LIMITED

Director

14/08/1995

14/08/1995

-

Active

NO

3

U85110MH1996PTC232761

MEYER HEALTH CARE PRIVATE LIMITED

Managing director

26/06/2009

26/06/1996

-

Amalgamated

NO

4

U45201KA2001PTC029728

MONT BLANC ENTERPRISES PRIVATE LIMITED

Director

14/04/2008

14/04/2008

-

Active

NO

5

U74990MH2012PTC226693

ANALYTICA CONTROL SERVICES PRIVATE LIMITED

Director

30/09/2013

28/05/2013

-

Active

NO

6

U24231MH2002PTC134735

VITABIOTICS (INDIA ) PRIVATE LIMITED

Director

30/09/2013

28/05/2013

-

Active

NO

7

U24239MH1981PTC023845

MEYER ORGANICS PRIVATE LIMITED

Director

30/09/2013

07/06/2013

-

Active

NO

 

 

Name :

Mrs. Uma Paul Kalekar

Designation :

Director

Address :

203, Iris, C Unati Garden Opposite Devdaya Nagar, Pokharan RDI, Thane-401606, Maharashtra, India

Date of Birth/Age :

27.01.1967

Date of Appointment :

14.07.2006

DIN No.:

01725745 

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231MH2002PTC134735

VITABIOTICS (INDIA ) PRIVATE LIMITED

Director

30/01/2002

30/01/2002

-

Active

NO

2

U24240MH2003PTC138653

EUROPEX PHARMA PRIVATE LIMITED

Director

13/01/2003

13/01/2003

-

Strike off

NO

3

U85110MH1996PTC232761

MEYER HEALTH CARE PRIVATE LIMITED

Director

01/04/2003

01/04/2003

11/08/2006

Amalgamated

NO

4

U24231MH2005PTC151985

VITALIFE PRODUCTS PRIVATE LIMITED

Director

16/03/2005

16/03/2005

-

Strike off

NO

5

U24239MH1981PTC023845

MEYER ORGANICS PRIVATE LIMITED

Director

14/07/2006

14/07/2006

-

Active

NO

6

U74990MH2012PTC226693

ANALYTICA CONTROL SERVICES PRIVATE LIMITED

Director

10/02/2012

10/02/2012

-

Active

NO

7

U70101KA1995PTC018530

MONT BLANC ESTATES PRIVATE LIMITED

Director

15/10/2012

15/10/2012

-

Active

NO

8

U45201KA2001PTC029728

MONT BLANC ENTERPRISES PRIVATE LIMITED

Director

15/10/2012

15/10/2012

-

Active

NO

9

U29253KA1983PTC005450

BRITISH TOOL HOUSE PRIVATE LIMITED

Director

15/10/2012

15/10/2012

-

Active

NO

 

 

Name :

Mr. Surinder Mohini Bawa

Designation :

Director

Address :

Guru Kripa House, 01 Jalandhar Road, Jalandhar – 144601, Punjab, India

Date of Birth/Age :

14.07.1935

Date of Appointment :

29.09.2012

DIN No.:

01741551

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U40101PB1969PLC002884

PUNJAB NYLON TRANSMISSION LTD

Managing director

25/07/1990

25/07/1990

-

Active

NO

2

U24239MH1981PTC023845

MEYER ORGANICS PRIVATE LIMITED

Director

29/09/2012

07/10/2011

-

Active

NO

3

U74990MH2012PTC226693

ANALYTICA CONTROL SERVICES PRIVATE LIMITED

Director

30/09/2013

28/05/2013

-

Active

NO

4

U24231MH2002PTC134735

VITABIOTICS (INDIA ) PRIVATE LIMITED

Director

30/09/2013

28/05/2013

-

Active

NO

 

 

Name :

Mrs. Rohini K Lalwani

Designation :

Director

Address :

1, Nariman Building, M Karve Road, Opposite Cooperage Ground, Mumbai-400021, Maharashtra, India

Date of Birth/Age :

21.08.1960

Date of Appointment :

08.07.2004

DIN No.:

02180066

 

 

KEY EXECUTIVES

 

Name :

Ms. Saruchi Athavle

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2013

 

Names of Shareholders

 

No. of Shares

Lalwani T Kartarsingh

 

94956

Lalwani Tej Kartarsingh

 

298320

Lalwani K Ajit

 

298320

Omega Meyer Limited, Island

 

122162

Lalwanin K Rohini

 

30000

Pushpa Kalsey

 

70

Bikra Kalsey

 

70

Total

 

843898

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2013

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

14.47

Directors or relatives of Directors

85.53

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacture of Pharmaceutical Formulation.

 

 

Products :

Products Description

ITC Code

Calcimax 500 Tablets

Calcimax Forte Tabs

Reeshape Capsules

Ovacare Tablets

 

30031000

 

PRODUCTION STATUS (As on 31.03.2011)

 

Particulars

Unit

Actual Production

Pharmaceutical Formulations

 

 

Tablets and Capsules

(No. In lakhs)

9332.08

Syrup

(in litres)

15,66,264.27

Cream/Granules

(in kgs.)

42,045.41

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available (We tried to confirm the number of employees but no one is ready to part any information from the company management).

 

 

Bankers :

Citi Bank N.A, Bandra Kurla Complex, G-Block, Bandra (East), Mumbai-400051, Maharashtra, India

 

 

Facilities :

SECURED LOANS

31.03.2012

Rs. In Millions

31.03.2011

Rs. In Millions

Long Term Borrowings

 

 

Rupee term loans from bank

43.016

59.405

Total

43.016

59.405

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

GPS and Associates

Chartered Accountants

Address :

A-1, Sindhi Niwas, Sitaladevi Temple Road, Mahim, Mumbai - 400016, Maharashtra, India

Tel. No.:

91-22-24468959 / 24446688 / 24441348 / 24440777

Fax No.:

91-22-24466455

E-Mail :

mail@gpsind.com

PAN.:

AADFG4422H

 

 

Associates :

  • Omega Meyer Limited
  • Adler Products Limited
  • Vitabiotics Limited
  • Vitabiotics (Nigeria) Limited
  • Farmex Meyer Limited
  • Vita Aria Company
  • Omega Meyer Ghana Limited
  • Vitabiotics Egypt Pharmaceuticals
  • Vitabiotics Tehran Limited
  • Nutritional Circle Limited
  • Pt. Vitabiotics Healthcare
  • Pt. Vitabiotics Utama Indonesia
  • Vitabiotics SA Sister Company
  • Meyer Health Care Private Limited

CIN No.: U85110MH1996PTC232761

 


 

CAPITAL STRUCTURE

 

As on 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

Rs.10/- each

Rs.10.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

843898

Equity Shares

Rs.10/- each

Rs.8.439 Millions



As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

Rs.10/- each

Rs.10.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

493898

Equity Shares

Rs.10/- each

Rs.4.939 Millions



 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

4.939

4.999

(b) Reserves & Surplus

 

1,143.687

722.523

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

1,148.626

727.522

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

26.776

21.073

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

26.776

21.073

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

43.016

59.405

(b) Trade payables

 

285.389

401.865

(c) Other current liabilities

 

38.944

37.415

(d) Short-term provisions

 

131.002

70.583

Total Current Liabilities (4)

 

498.351

569.268

 

 

 

 

TOTAL

 

1,673.753

1,317.863

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

321.359

301.511

(ii) Intangible Assets

 

2.962

3.941

(iii) Capital work-in-progress

 

0.867

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.049

0.049

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

325.237

305.501

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

396.498

432.224

(c) Trade receivables

 

333.614

275.119

(d) Cash and cash equivalents

 

526.415

210.067

(e) Short-term loans and advances

 

44.711

43.343

(f) Other current assets

 

47.278

51.609

Total Current Assets

 

1,348.516

1,012.362

 

 

 

 

TOTAL

 

1,673.753

1,317.863

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

4.999

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

522.610

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

527.609

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

56.836

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

56.836

DEFERRED TAX LIABILITIES

 

 

0.000

 

 

 

 

TOTAL

 

 

584.445

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

236.738

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.059

DEFERRED TAX ASSETS

 

 

7.639

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 
246.353

 

Sundry Debtors

 
 
294.724

 

Cash & Bank Balances

 
 
92.214

 

Other Current Assets

 
 
0.000

 

Loans & Advances

 
 
65.840

Total Current Assets

 

 

699.131

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

188.280

 

Other Current Liabilities

 
 
163.117

 

Provisions

 
 
7.725

Total Current Liabilities

 

 

359.122

Net Current Assets

 

 

340.009

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

584.445

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

3115.804

2660.301

2103.314

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                        

NA

NA

NA

 

 

 

 

 

 

EXPENSES

NA

NA

NA

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

690.286

373.926

292.828

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

3.428

4.445

7.013

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

686.858

369.481

285.815

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

28.314

23.883

18.145

 

 

 

 

 

 

Prior Period Expenses

0.000

0.301

0.000

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX

658.544

345.297

267.670

 

 

 

 

 

Less

TAX                                                     

219.695

139.555

92.030

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

438.849

345.297

267.670

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

43.944

19.000

21.600

 

BALANCE CARRIED TO THE B/S

394.905

186.742

108.443

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Manufactured goods Sale 

658.709

583.081

428.704

 

 

Trading Goods Sale

344.711

311.596

293.466

 

TOTAL EARNINGS

 1003.420

894.677

722.170

 

 

 

 

 

 

Earnings Per Share (Rs.)

520.03

411.57

359.31

 

 


KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

Net Profit Margin

(PBT/Sales)

(%)

21.14

12.98

12.73

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

39.37

26.20

20.31

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.57

0.47

0.37

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.04

0.08

0.08

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.71

1.78

1.99

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2010

31.03.2011

31.03.2012

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

4.999

4.999

4.939

Reserves & Surplus

522.610

722.523

1143.687

Net worth

527.609

727.522

1148.626

 

 

 

 

Secured Loans 

0.000

0.000

0.000

Unsecured Loans 

56.836

59.405

43.016

Total borrowings

56.836

59.405

43.016

Debt/Equity ratio

0.108

0.082

0.037

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2010

31.03.2011

31.03.2012

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

2,103.314

2,660.301

3,115.804

 

 

26.481

17.122

 

 

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2010

31.03.2011

31.03.2012

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

2,103.314

2,660.301

3,115.804

Profit

267.670

345.297

438.849

 

12.73%

12.98%

14.08%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

PERFORMANCE AND GROWTH:

 

The Company has shown a good performance during the year under review and the total sales (Domestic and Exports) had increased from Rs.2656.402 Millions to Rs.3111.102 Millions, registering an increase of 17% in sales.

 

The Company achieved a net profit of Rs.614.370 Millions as compared to previous year Rs.345.297 Millions, There is rise in Net profit ratio from 12.86 % to 20.96%. The Export turnover was Rs.10034.20 Lacs as compared to the previous year of Rs.894.677 Millions.

 

The Company attributes the growth in sales and profit due to The innovative skills and strategic planning implemented by the Marketing and sales personnel in order to achieve the best performance in the highly competitive pharmaceutical market. Discontinuation of Royalty and Agency Commission Gain in Foreign Exchange Increase in Interest income on Fixed Deposits.

 

 


INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10068376

12/09/2007

20,000,000.00

CITIBANK N. A.

Citigroup Centre, Bandra Kurla Complex, G Block Bandra East, Mumbai, Maharashtra - 400051, India

A23054091

2

10068380

06/08/2007

20,000,000.00

CITIBANK N. A.

Citigroup Centre, Bandra Kurla Complex, G Block Bandra East, Mumbai, Maharashtra - 400051, India

A23103005

3

10007119

26/04/2006

10,000,000.00

CITIBANK N. A.

Citigroup Centre, Bandra Kurla Complex, G Block Bandra East, Mumbai, Maharashtra - 400051, India

A00600700

4

90194458

17/05/2007 *

17,500,000.00

CITIBANK N. A.

Citigroup Centre, Bandra Kurla Complex, G Block Bandra East, Mumbai, Maharashtra - 400051, India

A25240235

5

90148203

25/01/2007 *

80,000,000.00

CITIBANK N. A.

Citigroup Centre, Bandra Kurla Complex, G Block Bandra East, Mumbai, Maharashtra - 400051, India

A12278156

6

90144378

29/07/2008 *

162,500,000.00

CITIBANK N. A.

Citigroup Centre, Bandra Kurla Complex, G Block Bandra East, Mumbai, Maharashtra - 400051, India

A43391127

*Date of modification Charges

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.38

UK Pound

1

Rs.101.63

Euro

1

Rs.83.50

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

SUM

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

58

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.